PaulWSpearmanMD
Pediatric Infectious Disease • Cincinnati, OHVice Chair for Clinical and Translational Research; Professor, Infectious Diseases
Dr. Spearman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
# ML7017
Cincinnati, OH 45229Phone+1 513-636-4578Fax+1 513-636-7039
Summary
- Dr. Paul Spearman is a pediatric infectious disease specialist at Cincinnati Children's Hospital Medical Center. He is Vice Chair for Clinical and Translational Research at Cincinnati Children's. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 34 years. Dr. Spearman's research program studies basic aspects of HIV virology, virus-host interactions, and vaccine development.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Infectious Disease, 1990 - 1994
Ohio State University HospitalResidency, Internal Medicine, 1986 - 1990
University of Texas Southwestern Medical SchoolClass of 1986
Certifications & Licensure
OH State Medical License 1987 - 2026
IN State Medical License 2021 - 2025
KY State Medical License 2021 - 2024
GA State Medical License 2005 - 2017
TN State Medical License 1994 - 2007- American Board of Internal Medicine Infectious Disease
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents Start of enrollment: 2021 Aug 06
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 15 citationsAdvances in HIV-1 Assembly.Grigoriy Lerner, Nicholas Weaver, Boris Anokhin, Paul Spearman
Viruses. 2022-02-26 - 1 citationsHIV-1 Broadly Neutralizing Antibodies Take the Road Less Traveled, and That Makes All the Difference.Krishnan Roskin, Paul Spearman
Cell Host & Microbe. 2020-04-08 - 14 citationsThe ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.Cindy Buffone, Juliane Kutzner, Silvana Opp, Alicia Martinez-Lopez, Anastasia Selyutina
Virology. 2019-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
